Information about the shortage of the medicinal product Diamox 250 mg tablets (acetazolamide)
22.08.2013
Medical Intertrade d.o.o., the marketing authorisation holder for the medicinal product Diamox 250 mg tablets (acetazolamide) has informed the Agency for Medicinal Products and Medical Devices about the shortage of the aforementioned medicine on the Croatian market. The shortage is due to manufacturing problems.
The normalisation of the supply chain with that medicine is expected in January 2014. During that period the medicinal product for the treatment of Croatian patients will be provided under the legal exemption scheme for products that are not authorised in Croatia.
